ArticleCancer control : journal of the Moffitt Cancer Center

Systemic Inflammatory Biomarkers Predict Survival of Patients Treated With Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma.

Zhaojuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.